Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Gains from Sales and Divestitures (2018 - 2024)

STRATA Skin Sciences' Gains from Sales and Divestitures history spans 7 years, with the latest figure at $2265.0 for Q4 2024.

  • On a quarterly basis, Gains from Sales and Divestitures fell 87.38% to $2265.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $2265.0, a 87.38% decrease, with the full-year FY2024 number at $2265.0, down 87.38% from a year prior.
  • Gains from Sales and Divestitures hit $2265.0 in Q4 2024 for STRATA Skin Sciences, roughly flat from $2265.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for SSKN hit a ceiling of $158407.0 in Q4 2022 and a floor of $1414.0 in Q2 2024.
  • Historically, Gains from Sales and Divestitures has averaged $64465.6 across 5 years, with a median of $55547.0 in 2020.
  • Biggest five-year swings in Gains from Sales and Divestitures: soared 298.66% in 2023 and later tumbled 98.23% in 2024.
  • Tracing SSKN's Gains from Sales and Divestitures over 5 years: stood at $68091.0 in 2020, then skyrocketed by 114.95% to $146364.0 in 2021, then increased by 8.23% to $158407.0 in 2022, then crashed by 88.67% to $17944.0 in 2023, then crashed by 87.38% to $2265.0 in 2024.
  • Business Quant data shows Gains from Sales and Divestitures for SSKN at $2265.0 in Q4 2024, $2265.0 in Q3 2024, and $1414.0 in Q2 2024.